Thoma Bravo Considering Sale of Software Company Apryse for Over $3 Billion, Sources Report

Lazard, Inc. (NYSE:LAZ) takes up a significant role in a high-profile potential transaction, as private equity powerhouse Thoma Bravo explores a $3 billion-plus sale of document software firm Apryse.

Lazard, Inc. (LAZ) to Guide $3B+ Apryse Sale

A close-up of a graph on a touchscreen, representing the latest investment trends.

Apryse, formerly PDFTron, has seen consistent growth. The company has reported an EBITDA of $100 million with an annual growth rate of more than 20%. According to Reuters, other private equity firms have started showing interest in the sale. As of now, Thoma Bravo is working on the sale with investment bankers at Lazard, Inc. (NYSE:LAZ), taking the lead advisory role.

The role comes amid internal and external recalibrations. Specifically, the company recently experienced executive reshuffling, with JP Morgan announcing on May 23, 2025, that the longtime software dealmaker Peter Duda was leaving Lazard, Inc. (NYSE:LAZ) to join it as a managing director supporting software.

While Lazard, Inc. (NYSE:LAZ)’s performance remains solid with a 3.31% weekly gain and a 13.52% monthly gain, a decline of 8.62% was noted in the insider stock transactions during the last six months, indicating a fall in insider confidence despite a positive stock performance.

Additionally, on May 15, 2025, Goldman Sachs reaffirmed a Sell rating on Lazard while raising the price target from $35 to $40, suggesting cautious optimism on the company’s growth amid an active deal environment.

While we acknowledge the potential of LAZ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LAZ and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds.

Disclosure: None.